Advertisement
Research Article

Comparison of Accuracy of Diabetes Risk Score and Components of the Metabolic Syndrome in Assessing Risk of Incident Type 2 Diabetes in Inter99 Cohort

  • Tracy B. Shafizadeh,

    Affiliation: Tethys Bioscience, Emeryville, California, United States of America

    X
  • Edward J. Moler,

    Affiliation: Tethys Bioscience, Emeryville, California, United States of America

    X
  • Janice A. Kolberg mail,

    jkolberg@tethysbio.com

    Affiliation: Tethys Bioscience, Emeryville, California, United States of America

    X
  • Uyen Thao Nguyen,

    Affiliation: Tethys Bioscience, Emeryville, California, United States of America

    X
  • Torben Hansen,

    Affiliation: Hagedorn Research Institute, Gentofte, Denmark

    X
  • Torben Jorgensen,

    Affiliations: Research Center for Prevention and Health, Glostrup Hospital, Copenhagen, Denmark, Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark

    X
  • Oluf Pedersen,

    Affiliations: Hagedorn Research Institute, Gentofte, Denmark, Institute of Biomedical Science, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark, Faculty of Health Science, University of Aarhus, Aarhus, Denmark, Novo Nordisk Foundation Center for Metabolic Research, University of Copenhagen, Copenhagen, Denmark

    X
  • Knut Borch-Johnsen

    Affiliations: Faculty of Health Science, University of Aarhus, Aarhus, Denmark, Institute Public Health, Research Center for Quality in Health Care, University of Southern Denmark, Odense, Denmark

    X
  • Published: July 29, 2011
  • DOI: 10.1371/journal.pone.0022863

Reader Comments (0)

Post a new comment on this article